Blood metagenomics next-generation sequencing has advantages in detecting difficult-to-cultivate pathogens, and mixed infections: results from a real-world cohort.

导出 LinkOut

翻译打印收藏纠错

第一作者： Mengjia,Qian

第一单位： Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.

作者： Mengjia,Qian ^[1] ; Chang,Li ^[1] ; Miaomiao,Zhang ^[1] ; Yanxia,Zhan ^[2] ; Bijun,Zhu ^[1] ; Lingyan,Wang ^[1] ; Qi,Shen ^[1] ; Lei,Yue ^[1] ; Hao,Chen ^[3] ; Yunfeng,Cheng ^[4]

作者单位： Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China. ^[1] Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China. ^[2] Department of Thoracic Surgery, Zhongshan-Xuhui Hospital, Fudan University, Shanghai, China. ^[3] Institute of Clinical Science, Zhongshan Hospital, Fudan University, Shanghai, China.;Department of Hematology, Zhongshan Hospital, Fudan University, Shanghai, China.;Center for Tumor Diagnosis & Therapy, Jinshan Hospital, Fudan University, Shanghai, China.;Department of Hematology, Zhongshan Hospital Qingpu Branch, Fudan University, Shanghai, China. ^[4]

关键词 blood diagnosis infection large cohort metagenomics next-generation sequencing (mNGS)real-world

主题词人类(Humans);高通量核苷酸序列分析(High-Throughput Nucleotide Sequencing);重症监护病房(Intensive Care Units);宏基因组学(Metagenomics)

DOI 10.3389/fcimb.2023.1268281

PMID 38188631

发布时间 2024-02-21

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交